Jeong Yoon Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jeong Yoon Kim has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Dae Wook Kim
Forest Plant Industry Department, Baekdudaegan National Arboretum, Bonghwa 36209, Korea
1 shared publication - Deok-Kun Oh
Department of Bioscience and Biotechnology Konkuk University Seoul Republic of Korea
1 shared publication - Hae Jin Cho
School of Biological Sciences and Institute of Microbiology, Seoul National University, Seoul, Korea
1 shared publication - Heung Joo Yuk
KM Science Research Division, Korea Institute of Oriental Medicine (KIOM), Daejeon 34054, Republic of Korea
1 shared publication - Hyun Sim Woo
Plant Resource Industry Division, Forest Plant Industry Department, Baekdudaegan National Arboretum, Bonghwa-gun 26209, Korea
1 shared publication - Ki Hun Park
Division of Applied Life Science (BK21 Four), IALS, Gyeongsang National University, Jinju 52828, Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 10 June 2020
- Published by MDPI AG in Biomolecules
- Vol. 10 (6) , 888
Bakkenolides and Caffeoylquinic Acids from the Aerial Portion of Petasites japonicus and Their Bacterial Neuraminidase Inhibition Ability
Petasites japonicus have been used since a long time in folk medicine to treat diseases including plague, pestilential fever, allergy, and inflammation in East Asia and European countries. Bioactive compounds that may prevent and treat infectious diseases are identified based on their ability to inhibit bacterial neuraminidase (NA). We aimed to isolate and identify bioactive compounds from leaves and stems of P. japonicas (PJA) and elucidate their mechanisms of NA inhibition. Key bioactive compounds of PJA responsible for NA inhibition were isolated using column chromatography, their chemical structures revealed using 1 H NMR, 13 C NMR, DEPT, and HMBC, and identified to be bakkenolide B (1), bakkenolide D (2), 1,5-di-O-caffeoylquinic acid (3), and 5-O-caffeoylquinic acid (4). Of these, 3 exhibited the most potent NA inhibitory activity (IC50 = 2.3 ± 0.4 μM). Enzyme kinetic studies revealed that 3 and 4 were competitive inhibitors, whereas 2 exhibited non-competitive inhibition. Furthermore, a molecular docking simulation revealed the binding affinity of these compounds to NA and their mechanism of inhibition. Negative-binding energies indicated high proximity of these compounds to the active site and allosteric sites of NA. Therefore, PJA has the potential to be further developed as an antibacterial agent for use against diseases associated with NA.
- 10 June 2020
- Published by MDPI AG in Biomolecules
- Vol. 10 (6) , 888
Open AccessBakkenolides and Caffeoylquinic Acids from the Aerial Portion of Petasites japonicus and Their Bacterial Neuraminidase Inhibition Ability
Petasites japonicus have been used since a long time in folk medicine to treat diseases including plague, pestilential fever, allergy, and inflammation in East Asia and European countries. Bioactive compounds that may prevent and treat infectious diseases are identified based on their ability to inhibit bacterial neuraminidase (NA). We aimed to isolate and identify bioactive compounds from leaves and stems of P. japonicas (PJA) and elucidate their mechanisms of NA inhibition. Key bioactive compounds of PJA responsible for NA inhibition were isolated using column chromatography, their chemical structures revealed using 1 H NMR, 13 C NMR, DEPT, and HMBC, and identified to be bakkenolide B (1), bakkenolide D (2), 1,5-di-O-caffeoylquinic acid (3), and 5-O-caffeoylquinic acid (4). Of these, 3 exhibited the most potent NA inhibitory activity (IC50 = 2.3 ± 0.4 μM). Enzyme kinetic studies revealed that 3 and 4 were competitive inhibitors, whereas 2 exhibited non-competitive inhibition. Furthermore, a molecular docking simulation revealed the binding affinity of these compounds to NA and their mechanism of inhibition. Negative-binding energies indicated high proximity of these compounds to the active site and allosteric sites of NA. Therefore, PJA has the potential to be further developed as an antibacterial agent for use against diseases associated with NA.
- 1 December 2016
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 193, 283-292
Potent bacterial neuraminidase inhibitors, anthraquinone glucosides from Polygonum cuspidatum and their inhibitory mechanism
- 1 December 2016
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 193, 283-292
Potent bacterial neuraminidase inhibitors, anthraquinone glucosides from Polygonum cuspidatum and their inhibitory mechanism